Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study

BACKGROUND: Recent in vitro and animal experiments suggest that peroxisome proliferation-activated receptor gamma (PPARɣ) agonist medications, such as antidiabetic glitazone (GTZ) drugs, are neuroprotective in models of Parkinson’s disease (PD). These findings have not been tested in humans. We hypo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS Med
Главные авторы: Brauer, Ruth, Bhaskaran, Krishnan, Chaturvedi, Nishi, Dexter, David T., Smeeth, Liam, Douglas, Ian
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511413/
https://ncbi.nlm.nih.gov/pubmed/26196151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1001854
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы